Abstract
Chronic use of drugs of abuse affects neuroimmune signaling; however, there are still many open questions regarding the interactions between neuroimmune mechanisms and substance use disorders (SUDs). Further, chronic use of drugs of abuse can induce glutamatergic changes in the brain, but the relationship between the glutamate system and neuroimmune signaling in addiction is not well understood. Therefore, the purpose of this review is to bring into focus the role of neuroimmune signaling and its interactions with the glutamate system following chronic drug use, and how this may guide pharmacotherapeutic treatment strategies for SUDs. In this review, we first describe neuroimmune mechanisms that may be linked to aberrant glutamate signaling in addiction. We focus specifically on the nuclear factor-kappa B (NF-κB) pathway, a potentially important neuroimmune mechanism that may be a key player in driving drug-seeking behavior. We highlight the importance of astroglial-microglial crosstalk, and how this interacts with known glutamatergic dysregulations in addiction. Then, we describe the importance of studying non-neuronal cells with unprecedented precision because understanding structure-function relationships in these cells is critical in understanding their role in addiction neurobiology. Here we propose a working model of neuroimmune-glutamate interactions that underlie drug use motivation, which we argue may aid strategies for small molecule drug development to treat substance use disorders. Together, the synthesis of this review shows that interactions between glutamate and neuroimmune signaling may play an important and understudied role in addiction processes and may be critical in developing more efficacious pharmacotherapies to treat SUDs.
Document Type
Review
Publication Date
2-21-2021
Digital Object Identifier (DOI)
https://doi.org/10.1186/s12974-021-02072-8
Funding Information
This work was supported by the National Institutes of Health Grant DA050427 (to BMS), DA040004 (to MDS), DA046526, DA036569, DA036569-S1, DA044479, DA049130, and DA045881 (all to CDG), DA045499, R01DA039139, and DA047169 (all to SR), and in part by the South Carolina Clinical & Translational Research (SCTR) Institute, with an academic home at the Medical University of South Carolina CTSA, NIH/NCATS Grant Number UL1 TR001450.
Related Content
All data and materials are available upon request.
Repository Citation
Gipson, Cassandra D.; Rawls, Scott; Scofield, Michael D.; Siemsen, Benjamin M.; Bondy, Emma O.; and Maher, Erin E., "Interactions of Neuroimmune Signaling and Glutamate Plasticity in Addiction" (2021). Family and Community Medicine Faculty Publications. 12.
https://uknowledge.uky.edu/familymedicine_facpub/12
Included in
Family Medicine Commons, Neurosciences Commons, Pharmacy and Pharmaceutical Sciences Commons
Notes/Citation Information
Published in Journal of Neuroinflammation, v. 18, article no. 56.
© The Author(s) 2021
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.